Heterogeneity between Diagnostic Tests for IgA anti-Beta2 Glycoprotein I: Explaining the Controversy in Studies of Association with Vascular Pathology-Reference-Cited by-同舟云学术

Heterogeneity between Diagnostic Tests for IgA anti-Beta2 Glycoprotein I: Explaining the Controversy in Studies of Association with Vascular Pathology

Published:2013-11-26 Issue:24 Volume:85 Page:12093-12098
ISSN:0003-2700
Container-title:Analytical Chemistry
language:en
Short-container-title:Anal. Chem.

Author:

Martínez-Flores José A.,Serrano Manuel,Alfaro Javier,Mora Sergio,Paz-Artal Estela¹,Morales José M.,Serrano Antonio¹

Affiliation:

1. Section of Immunology, Universidad San Pablo-CEU, Madrid, Spain

Publisher

American Chemical Society (ACS)

Subject

Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ac403194t

Reference53 articles.

1. Hughes Syndrome (the antiphospholipid syndrome)

2. Antiphospholipid Antibodies

3. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

4. The Antiphospholipid Syndrome

5. Pathogenic mechanisms mediating antiphospholipid syndrome

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Noncriteria antiphospholipid antibodies in antiphospholipid syndrome;International Journal of Laboratory Hematology;2024-04-07

2. Quantification of Antiphospholipid Antibodies: The Importance of Using an Appropriate Methodology for Each Clinical Profile;International Journal of Molecular Sciences;2023-12-12

3. Extra-criteria antiphospholipid antibodies in patients with small vessel brain lesions and clinical manifestations associated with antiphospholipid syndrome;Journal of Stroke and Cerebrovascular Diseases;2023-05

4. COVID-19 and the antiphospholipid syndrome;Autoimmunity Reviews;2022-12

5. Anticardiolipin IgA as a Potential Risk Factor for Pregnancy Morbidity in Patients with Antiphospholipid Syndrome;Laboratory Medicine;2022-05-29